Literature DB >> 18783972

Enhanced negative feedback sensitivity of the hypothalamus-pituitary-adrenal axis in chronic myogenous facial pain.

Ursula Galli1, Jens Gaab, Dominik A Ettlin, Fidel Ruggia, Ulrike Ehlert, Sandro Palla.   

Abstract

UNLABELLED: Dysregulations of the hypothalamus-pituitary-adrenal (HPA) axis, as a physiological substrate of stress, have been observed in patients with different stress-related and chronic pain disorders. In this study, we investigated possible dysregulations of the HPA axis in patients with masticatory muscles pain. In 20 patients with myogenous facial pain and 20 healthy controls, awakening cortisol responses, i.e.cortisol rise in the first hour after awakening, as well as a short circadian free cortisol profile, i.e. four cortisol samples over 12h during the day, were assessed before and after administration of 0.5mg dexamethasone.
RESULTS: In comparison to controls, chronic myogenous facial pain patients showed enhanced and prolonged suppression of cortisol after the administration of 0.5mg dexamethasone. Unstimulated cortisol response (before dexamethasone-intake) to awakening and cortisol levels during the day did not differ between the groups. Dysregulation in terms of enhanced negative feedback suppression exists in chronic myogenous facial pain. These results are in line with a multifactorial etiology of chronic facial pain, shifting the perspective away from a local towards a more central etiology with dysregulations in the stress and pain modulating system.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18783972     DOI: 10.1016/j.ejpain.2008.07.010

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  9 in total

Review 1.  A users guide to HPA axis research.

Authors:  Robert L Spencer; Terrence Deak
Journal:  Physiol Behav       Date:  2016-11-18

2.  Corticosterone pretreatment suppresses stress-induced hypothalamic-pituitary-adrenal axis activity via multiple actions that vary with time, site of action, and de novo protein synthesis.

Authors:  Chad Osterlund; Robert L Spencer
Journal:  J Endocrinol       Date:  2011-01-04       Impact factor: 4.286

3.  Glucocorticoid Fast Feedback Inhibition of Stress-Induced ACTH Secretion in the Male Rat: Rate Independence and Stress-State Resistance.

Authors:  Chad D Osterlund; Mariana Rodriguez-Santiago; Elizabeth R Woodruff; Ryan J Newsom; Anjali P Chadayammuri; Robert L Spencer
Journal:  Endocrinology       Date:  2016-05-04       Impact factor: 4.736

Review 4.  Inflaming the brain: CRPS a model disease to understand neuroimmune interactions in chronic pain.

Authors:  C Linnman; L Becerra; D Borsook
Journal:  J Neuroimmune Pharmacol       Date:  2012-11-29       Impact factor: 4.147

Review 5.  Central changes associated with chronic pelvic pain and endometriosis.

Authors:  Jennifer Brawn; Matteo Morotti; Krina T Zondervan; Christian M Becker; Katy Vincent
Journal:  Hum Reprod Update       Date:  2014-06-11       Impact factor: 15.610

Review 6.  Adrenal fatigue does not exist: a systematic review.

Authors:  Flavio A Cadegiani; Claudio E Kater
Journal:  BMC Endocr Disord       Date:  2016-08-24       Impact factor: 2.763

Review 7.  Mental Status as a Common Factor for Masticatory Muscle Pain: A Systematic Review.

Authors:  Mieszko Wieckiewicz; Marek Zietek; Joanna Smardz; Dobrochna Zenczak-Wieckiewicz; Natalia Grychowska
Journal:  Front Psychol       Date:  2017-05-09

8.  Temporomandibular Disorders Related to Stress and HPA-Axis Regulation.

Authors:  Kordian Staniszewski; Henning Lygre; Ersilia Bifulco; Siv Kvinnsland; Lisa Willassen; Espen Helgeland; Trond Berge; Annika Rosén
Journal:  Pain Res Manag       Date:  2018-05-02       Impact factor: 3.037

9.  Hypothalamus-Pituitary-Adrenal Axis Hypersuppression Is Associated with Gastrointestinal Symptoms in Major Depression.

Authors:  Pontus Karling; Mikael Wikgren; Rolf Adolfsson; Karl-Fredrik Norrback
Journal:  J Neurogastroenterol Motil       Date:  2016-04-30       Impact factor: 4.924

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.